Antiproliferation and apoptosis induced by tamoxifen in human bile duct carcinoma QBC939 cells via upregulated p53 expression

Biochemical and Biophysical Research Communications

Volumn 385, Issue 2, 2009, Pages 251-256

  Han, Peng ^a   Kang, Jin He ^a   Li, Hua Liang ^a   Hu, Su Xian ^b   Lian, Hui Hui ^a   Qiu, Ping Ping ^a   Zhang, Jian ^a   Li, Wen Gang ^b   Chen, Qing Xi ^a,c  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

^c XIAMEN UNIVERSITY   (China)

Author keywords

Antiproliferation; Apoptosis; Bile duct carcinoma; p53; Tamoxifen

Indexed keywords

CISPLATIN; DNA FRAGMENT; FLUOROURACIL; PROTEIN P53; TAMOXIFEN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; CANCER INHIBITION; CARCINOMA CELL; CELL ASSAY; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GEL ELECTROPHORESIS; HELA CELL; HUMAN; HUMAN CELL; MELANOMA B16; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; BILE DUCT NEOPLASMS; CARCINOMA; CELL PROLIFERATION; ESTROGEN ANTAGONISTS; HUMANS; TAMOXIFEN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 67349231921     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.05.059     Document Type: Article

References (16)

1. Groen P.C., Gores G.J., LaRusso N.F., Gunderson L.L., and Nagorney D.M. Biliary tract cancers. N. Engl. J. Med. 18 (1999) 1368-1378
2. Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2 (2002) 10
3. Lazaridis K.N., and Gores G.J. Cholangiocarcinoma. Gastroenterology 128 (2005) 1655-1667
4. Shaib Y., and El-Serag H.B. The epidemiology of cholangiocarcinoma. Semin. Liver Dis. 24 (2004) 115-125
5. Sirica A.E. Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy. Hepatology 41 (2005) 5-15
6. Tobias J.S. Endocrine approaches for the treatment of early and advanced breast cancer in postmenopausal women. Int. J. Biochem. Cell Biol. 36 (2004) 2112-2119
7. Grainger D.J., and Metcalfe J.C. Tamoxifen: teaching an old drug new tricks?. Nat. Med. 2 (1996) 381-385
8. Mandlekar S., and Kong A.N. Mechanisms of tamoxifen-induced apoptosis. Apoptosis 6 (2001) 469-477
9. Mosmman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
10. Earnshaw W.C., Martins L.M., and Kaufmann S.H. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 68 (1999) 383-424
11. Anderson C.D., Pinson C.W., Berlin J., and Chari R.S. Diagnosis and treatment of cholangiocarcinoma. Oncologist 9 (2004) 43-57
12. Salami S., and Karami-Tehrani F. Biochemical studies of apoptosis induced by tamoxifen in estrogen receptor positive and negative breast cancer cell lines. Clin. Biochem. 36 (2003) 247-253
13. Yu J., and Zhang L. The transcriptional targets of p53 in apoptosis control. Biochem. Biophys. Res. Commun. 331 (2005) 851-858
14. Tompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science 267 (1995) 1456-1462
15. Izban K.F., Wrone-Smith T., His E.D., Shcnitzer B., Ouevedo M.E., and Alkan S. Characterization of the interleukin-1beta-converting enzyme/ced3-family protease, caspase-3/CPP32, in Hodgkin's disease: lack of caspase-3 expression in nodular lymphocyte predominance Hodgkin's disease. Am. J. Pathol. 154 (1999) 1439-1447
16. Hashimoto M., Inoue S., Muramatsu M., and Masliah E. Estrogens stimulate tamoxifen-induced neuronal cell apoptosis in vitro: a possible genomic action. Biochem. Biophys. Res. Commun. 2402 (1997) 464-470